Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Six-month randomized comparison of SAR342434 vs Humalog in adult type 1 diabetes patients using insulin glargine
2013-002945-12Phase 3Completed
- Sponsor
- Sanofi
- Start
- Aug 2014
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of insulin lispro (Wockhardt) in diabetes mellitus type 1 (T1D) (2 arms), sponsored by Sanofi. Primary endpoint: Change in HbA1c from baseline. Started Aug 2014; status: completed.
02
Drugs
insulin lispro (Wockhardt)
03
Conditions
diabetes mellitus type 1 (T1D)
Beyond the preview
Go deeper on 2013-002945-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-002945-12.